In August 2016, Sandy DiCesare stepped into the role of Chief Operating Officer. In this role, DiCesare oversees ZappRx’s daily operations, finances, and staffing initiatives. DiCesare previously served as Vice President, Commercial Operations at Takeda Oncology, formerly known as Millennium Pharmaceuticals and founded in 1993.
During DiCesare’s 17-year tenure at Takeda Oncology, she spearheaded the operating strategy, and as a result, helped transform the company from a small Cambridge-based genomics group to a global, fully integrated biopharmaceutical company. In 2008, Millennium was acquired by Takeda Pharmaceutical Company Limited, forming Millennium: The Takeda Oncology Company.